Kite Pharma
Biopharmaceutical company focused on CAR-T cell therapies for cancer; acquired by Gilead Sciences for $11.9B in 2017 and now operates as a Gilead subsidiary.
Santa Monica, United States · 2+ investments · 2 portfolio companies
- Headquarters
- Santa Monica, United States
- Founded
- 2009
- Website
- kitepharma.com
- Portfolio Companies
- 2
- Total Investments
- 2
- Last Investment
- May 2023
- Geographic Focus
- United States
Investment Thesis
Kite Pharma is a Venture Capital firm based in Santa Monica, United States. It has made 2 investments, including Ensoma and Cell Design Labs. Focus areas include Biotech and Healthcare.
Portfolio2
Co-investors11
Sign up to view co-investors
11 co-investors across 11 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×9 · Private Equity ×1 · Hedge Fund ×1 · 4 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/kite-pharma"><img src="https://indexed.vc/api/badge/investor/kite-pharma" alt="Kite Pharma on Indexed.vc" width="260" height="76" /></a>